	Prior response to anti-VEGF agents predicts the efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer. Int J Clin Oncol Hirakawa M, Sagawa T, Okagawa Y, Suzuki N, Fujikawa K, Takada K. PMID: 42062697 [PubMed - as supplied by publisher]
	Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection. NPJ Precis Oncol Oyoshi H, Bando H, Yamashita R, Kageyama SI, Nakamura Y, Horasawa S, Nakamura M, Fujisawa T, Tomizawa K, Motegi A, Hojo H, Hirata H, Yukami H, Mishima S, Kotani D, Miyo M, Ando K, Watanabe J, Akazawa N, Kataoka K, Taniguchi H, Oki E, Takemasa I, Kato T, Mori M, Jurdi A, Liu MC, Misumi T, Zenda S, Yoshino T. PMID: 42062528 [PubMed - as supplied by publisher]
	Excessive lymph node dissection compromises efficacy of postsurgical immunotherapy for gastric cancer:A multicenter retrospective study. Cancer Lett Yang J, You J, Li T, Zhang Z, Zeng W, Wang Q, Chen C, Li Y, Li C, Yi Z, Huang L, Liang R, Wang H, Huang H, Ding D, Lu L, Wei B. PMID: 42061804 [PubMed - as supplied by publisher]
	Microbiota-Targeted Nanoplatforms for Colorectal Cancer Immunotherapy. Pharmacol Res Li SQ, Wang JN, Zhao SN, Feng G, Sun YD. PMID: 42061776 [PubMed - as supplied by publisher]
	Multifaceted roles of the NLRC4 inflammasome in cancer: from molecular mechanisms to therapeutic implications. J Mol Biol Zhang Z, Li Y, Lv Z, Man SM. PMID: 42061503 [PubMed - as supplied by publisher]
	CLO26-077: Outcomes of Laparoscopic Complete Mesocolic Excision for Colon Cancer With Optimized Lymph Node Harvest Using GEWF Solution: A Prospective Study. J Natl Compr Canc Netw Nguyen TM, Dang TC, Nguyen STB, Pham CN, Le DD, Pham DM, Nguyen TH, Phan DDT, Van Nguyen PD, Nguyen PT, Doan VP, Nguyen SD, Pham VA. PMID: 42061464 [PubMed - in process]
	Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium. Lancet Oncol Widder J, Bol GM, Simek IM, Ehret F, Abdel-Aty H, Basic S, Chuter D, Daly J, Fairbrother P, Zeqa D, Aboubakar Nana F, Achard V, Corradini S, Correia D, De Ruysscher D, Dingemans AC, Faivre-Finn C, Gillessen S, Guren MG, Hendriks L, Kunz WG, Lecouvet FE, Levy A, Lievens Y, McDonald F, Meattini I, Oppong F, Oprea-Lager D, Palma D, Fredberg Persson G, Remon J, Vandemaele M, van Laarhoven HWM, Verkooijen HM, Visani L, Zilli T, Ost P, Guckenberger M. PMID: 42061381 [PubMed - indexed for MEDLINE]
	Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types. Lancet Oncol Ward ZJ, Moraes FY, Scott AM, Favorito FM, Ngwa W, Rebbeck TR, Gopal S, Dako F, Avery S, Loehrer PJ, Hricak H. PMID: 42061369 [PubMed - indexed for MEDLINE]
	Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers. Lancet Oncol Ward ZJ, Moraes FY, Scott AM, Rebbeck TR, Loehrer PJ, Hricak H. PMID: 42061367 [PubMed - indexed for MEDLINE]
	Alcohol consumption and cancer progression: Mechanistic insights, immune dysregulation, and public health implications. Transl Oncol Deshpande RP, Tyagi A, Watabe K. PMID: 42061045 [PubMed - as supplied by publisher]
	Individualised prediction of HER2 status in colorectal cancer: development and validation of a radiomics prediction model using (18)F-fluorodeoxyglucose positron emission tomography/magnetic resonance ((18)F-FDG PET/MR). Clin Radiol Yuan Z, Ding J, Cao Z, Zhou Z, Chen X, Wang W, Zhao J, Qi N. PMID: 42060950 [PubMed - as supplied by publisher]
	Asynchronous telerehabilitation in prehabilitation and postoperative recovery for colorectal cancer: A protocol for a randomized controlled trial. PLoS One Burgos-Bragado JM, Jiménez-Sánchez C, Brandín-de la Cruz N, Carpallo-Porcar B, Roux-Ethève LL, Blas-Laina JL, Alamillo-Salas J, Gracia Gimeno P, Calvo S. PMID: 42060648 [PubMed - indexed for MEDLINE]
	Effects of a resistance training program on chemotherapy-induced peripheral neuropathy, cancer-related fatigue, muscle strength and physical activity in colorectal cancer patients undergoing chemotherapy: a pilot randomized controlled trial. Clin Transl Oncol Martín-Sánchez C, Fernández-Rodríguez EJ, Fonseca-Sánchez E, Mateos YL, Espinal-Matos S, Martín-Vallejo J, García-Martín A, Cruz-Hernández JJ, González JLS. PMID: 42060079 [PubMed - as supplied by publisher]
	The Role of Thyroidectomy in the Management of Thyroglossal Duct Carcinoma: A Systematic Review. Otolaryngol Head Neck Surg IJtsma HH, van Dijk SPJ, Cunningham CE, van Kemenade FJ, Peeters RP, Keereweer S, van Ginhoven TM. PMID: 42059047 [PubMed - as supplied by publisher]
	Prognostic significance and clinicopathological associations of tumor budding and poorly differentiated clusters in endometrioid endometrial carcinoma. Turk J Med Sci Mavili HS, Atmi, Pehlivan FS, Çavdaro, Kandilo. PMID: 42058980 [PubMed - indexed for MEDLINE]
	Dynamic systemic immune-inflammation index predicts survival after neoadjuvant immunotherapy in gastric cancer: A multicenter study. iScience Zheng HL, Shen LL, Lv CB, Lin J, Xu BB, Xue Z, Lu J, Zheng ZW, Huang CM, Wang JB, Zheng CH. PMID: 42058904 [PubMed]
	In vitro studies on curcumin-chitosan-Multiwalled Carbon Nanotubes (MWCNT) cytotoxicity against A549 (lung cancer cell line) HCT 116 (colorectal cancer cell line) and PANC1 (pancreatic cancer cell line). Toxicol Rep Rabba'a MM, Abu-Zurayk RA, Bustanji YK, Abu-Irmaileh B, Mallouh SA, Khalaf A. PMID: 42058868 [PubMed]
	Transcutaneous Electrical Acupoint Stimulation for Opioid Tolerance in Hepatocellular Carcinoma and Proteomics Analysis: A Randomized Controlled Trial Protocol. J Pain Res Luo Z, Wu H, Pan J, Liu HR, Huang Y, Xu H, Wang Q, Wu L, Zhu L. PMID: 42058818 [PubMed]
	Direct oral anticoagulants vs LMWH for cancer-associated thrombosis - updated evidence on bleeding risk, recurrence and patient-reported outcomes: A systematic review. World J Methodol Asad D, Abid A, Hassan MB, Nenwani MK, Dev S, Kumar S, Sapna F, Bai P, Siddique S, Jawed I, Alam F, Razzaq FA, C Mekowulu F, Jabeen S, Mirza AM. PMID: 42058802 [PubMed]
	Nivolumab plus ipilimumab and cobimetinib in previously treated microsatellite-stable/DNA mismatch repair-proficient metastatic colorectal cancer: the phase II CheckMate 142 trial. ESMO Gastrointest Oncol Overman MJ, McCraith S, He B, Jin L, Lei M, Yao J, Morse MA. PMID: 42058638 [PubMed]

Articles 1 - 20 / 239085

Page 1 of 11955



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy